OpenAlex
PricingAboutJobs
Log inGet started
Work

Cost-effectiveness of umeclidinium/vilanterol versus aclidinium monotherapy for symptomatic COPD in Colombia: a lifetime Markov model

HTML

Year: 2026
Type: article
Source: Expert Review of Pharmacoeconomics & Outcomes Research
DOI: 10.1080/14737167.2026.2767344
Author: Jefferson Antonio Buendía
Institution: Universidad de Antioquia
Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: umeclidinium/vilanterol, aclidinium, chronic obstructive pulmonary disease, cost-effectiveness, COPD maintenance therapy, COPD exacerbations, quality-adjusted life years, net monetary benefit
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7236021693
FWCI:
Cites: 16
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security